Release Date: 27/02/15 16:07 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 123.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%